Skinbiotherap. Share News (SBTX)

Skinbiotherap. Information

Buy SBTX Shares
Add SBTX to Watchlist
Add SBTX to Alert

Share Price Information for Skinbiotherap. (SBTX)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 9.25

Bid: 9.00

Ask: 9.50

Change: 0.00 (0.00%)

Spread: 0.50 (5.556%)

Open: 9.25

High: 9.25

Low: 9.25

Prev. Close: 9.25

Last checked at -

SkinBioTherapeutics proposes Manprit Singh Randhawa as new CFO

Mon, 28th Mar 2022 09:57

(Alliance News) - SkinBioTherapeutics PLC on Monday said it has proposed to appoint Manprit Singh Randhawa as its new chief financial officer.

The skin health-focused life sciences company said Randhawa will replace current part-time CFO Doug Quinn upon nominated adviser confirmation of his appointment.

Randhawa most recently worked as CFO at Chelmsford, England-based educational technology firm, Juniper Education Group.

"We have changed the CFO position from part-time to a full-time role to reflect the new commercial path of the business," Chair Martin Hunt said.

Meanwhile, the Macclesfield-based firm proposed the appointment of Danielle Bekker as non-executive director.

SkinBioTherapeutics shares were 1.5% lower at 48.25 pence each in London on Monday morning.

By Tom Budszus; tombudszus@alliancenews.com

More News

21 Nov 2023 15:08

EARNINGS AND TRADING UPDATES: Accsys narrows interim pretax loss

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

17 Nov 2023 11:35

IN BRIEF: SkinBioTherapeutics share placing raises GBP3 million

SkinBioTherapeutics PLC - Newcastle, England-based life science company focused on skin health - Raises GBP3.0 million through placing of 15.9 million shares at 19 pence each. Says placing was completed through an accelerated bookbuild and was "materially oversubscribed". Placing price represents a 9.5% discount to SkinBio's closing middle market price of 21p per share on November 15, the day before it launched the placing. Company says the placing shares will be admitted to AIM on Wednesday and will represent around 9.2% of its total issued share capital.

16 Nov 2023 19:30

TRADING UPDATES: Instem acquisition by Ichor sanctioned by UK court

(Alliance News) - (Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

1 Nov 2023 11:55

OptiBiotix says market still "volatile" but partner sales improving

(Alliance News) - OptiBiotix Health PLC on Wednesday said sales from existing partners have improved in recent months, and that its move to focus on US and Asian markets is progressing well.

25 Oct 2023 14:39

TRADING UPDATES: SkinBio trading as expected; Sylvania output up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

25 Oct 2023 09:08

SkinBioTherapeutics launches new consumer study into acne

(Sharecast News) - Life sciences company SkinBioTherapeutics said on Wednesday that it had begun a new consumer study into acne, with two new formulas set to be trialled in order to compare efficacy against "the most common skin condition".

19 Oct 2023 12:10

IN BRIEF: SkinBio extends collaboration with Sederma for SkinBiotix

SkinBioTherapeutics PLC - Newcastle-based life science company focused on skin health - Extends its collaboration contract with Sederma SAS, the cosmetics arm of Croda International PLC, for another 12 months. Says the extension is so Sederma can complete and assess further studies on SkinBiotix technology to look at "previously unseen beneficial properties", which could "significantly enhance commercial opportunities". Sederma will cover any costs of SkinBioTherapeutics concerning the supply of SkinBiotix for the studies."We are confident that this can lead to a wider commercialisation of our SkinbiotixTM technology into new products, which can make a great difference to consumers with a wide array of skincare needs," says CEO Stuart Ashman.

19 Oct 2023 10:37

AIM WINNERS & LOSERS: OnTheMarket surges on CoStar takeover

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

15 Sep 2023 10:18

SkinBio gets approval to launch psoriasis treatment in France

(Alliance News) - SkinBioTherapeutics PLC on Friday said it has received approval from regulators to sell AxisBiotix-Ps, a food supplement designed to treat symptoms of psoriasis, to consumers in France.

15 Sep 2023 10:11

SkinBioTherapeutics gets France approval for psoriasis supplement

(Sharecast News) - SkinBioTherapeutics has been given the green light by French regulators to introduce its food supplement, AxisBiotix-Ps, into the French market, it announced on Friday.

5 Sep 2023 17:35

TRADING UPDATES: Literacy Capital nets profit on Butternut Box sale

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

5 Sep 2023 12:44

SkinBioTherapeutics selects probiotic blends for acne study

(Sharecast News) - Skin health specialist SkinBioTherapeutics updated the market on its decision on the probiotic blends to be used in a consumer volunteer study aimed at acne treatment on Tuesday.

21 Jun 2023 17:00

SkinBioTherapeutics launching psoriasis supplement in Italy

(Sharecast News) - Skin health specialist SkinBioTherapeutics has received regulatory approval to introduce 'AxisBiotix-Ps' - a food supplement designed to alleviate the symptoms associated with psoriasis - into the Italian market, it announced on Wednesday.

21 Jun 2023 10:48

IN BRIEF: SkinBioTherapeutics to launch AxisBiotix-Ps in Italy

SkinBioTherapeutics PLC - Newcastle-based life science company focused on skin health - Receives regulatory approval to issue AxisBiotix-Ps in Italy. This follows the launch of AxisBiotix-Ps in Spain, after having received approval in March. Says the next target country for launch of the product is France, with talks with French regulators already underway. AxisBiotix-Ps is a food supplement used to alleviate Psoriasis symptoms.

14 Jun 2023 18:24

IN BRIEF: SkinBioTherapeutics knows no reason for share price fall

SkinBioTherapeutics PLC - life science company focused on skin health - Notes share price slide but says "not aware of any rationale for the movement".

Latest Share Chat

Skinbiotherap. Share News (SBTX)

Share Price Information for Skinbiotherap. (SBTX)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SkinBioTherapeutics proposes Manprit Singh Randhawa as new CFO

Login to your account

Quickpicks are a member only feature

Login to your account